Skip to main content
logo
NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0021
0.00 (0.00%)
Aug 31, 2026, 9:52 AM EST

NKGen Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-23.55-44.29-82.95-26.75-23.27
Depreciation & Amortization
1.371.321.21.211.24
Loss (Gain) From Sale of Assets
00.01---
Stock-Based Compensation
3.734.144.140.070.09
Other Operating Activities
-1.1816.5753.442.891.45
Change in Accounts Receivable
--0.03-0.030.11
Change in Accounts Payable
1.492.263.990.440.96
Change in Other Net Operating Assets
-1.5-0.89-1.8-0.38-0.14
Operating Cash Flow
-19.65-20.88-21.95-22.56-19.55
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
----0.1-0.4
Sale of Property, Plant & Equipment
-0.04---
Sale (Purchase) of Intangibles
-0.1-0.05-0.05-0.06-0.06
Investing Cash Flow
-0.1-0.01-0.05-0.16-0.46

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1.1810.292320.5
Long-Term Debt Issued
-16.1916.22--
Total Debt Issued
17.7817.3726.512320.5
Short-Term Debt Repaid
--1.84-0.3-0.68-0.4
Long-Term Debt Repaid
--1.17---
Total Debt Repaid
-4.01-3.01-0.3-0.68-0.4
Net Debt Issued (Repaid)
13.7714.3526.2122.3320.1
Issuance of Common Stock
5.213.461.680.160.06
Other Financing Activities
0.513.04-5.73--
Financing Cash Flow
19.4920.8522.1622.4920.16

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-0.26-0.040.16-0.230.15

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-19.65-20.88-21.95-22.66-19.95
Free Cash Flow Growth
-----
Free Cash Flow Margin
----29425.97%-4683.33%
Free Cash Flow Per Share
-0.56-0.72-1.42-3.56-1.40
Levered Free Cash Flow
-20.95-26.9111.32-16.94-
Unlevered Free Cash Flow
-19.59-25.211.78-15.5-

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.021.372.230.030.93